Inventor · disambiguated record
Shuguang Zhu
Also filed as: ZHU SHUGUANG
6 granted patents·11 pending applications·45 citations·filing 2001–2021
81Inventor score
Files withCAI SHAOPEI4NOVARTIS VACCINES & DIAGNOSTIC3CHIRON CORP2NANODESIGN INC2RECURIUM IP HOLDINGS LLC2
Top patents by PatentIndex Score
17 records- 0183US7825132B2Inhibition of FGFR3 and treatment of multiple myelomaNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Nov 2, 2010·19 cites·9 claims
- 0278US8614216B2Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid saltsOKHAMAFE AUGUSTUS O·Filed 2012·Granted Dec 24, 2013·8 cites·27 claims
- 0367US7838527B2Methods of treating cancer and related methodsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Nov 23, 2010·5 cites·47 claims
- 0465US2009181979A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Application pending·0 cites
- 0561US6599921B2Non-steroidal estrogen receptor ligandsNANODESIGN INC·Filed 2001·Granted Jul 29, 2003·4 cites·22 claims
- 0660US2014303182A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCAI SHAOPEI·Filed 2014·Application pending·0 cites
- 0759US2013338171A1Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical PropertiesCAI SHAOPEI·Filed 2013·Application pending·0 cites
- 0857US2005209247A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCHIRON CORP·Filed 2004·Application pending·0 cites
- 0957US2005137399A1Methods for synthesizing quinolinone compoundsCHIRON CORP·Filed 2004·Application pending·0 cites
- 1056US2012277434A1Methods for synthesizing quinolinone compoundsCAI SHAOPEI·Filed 2012·Application pending·0 cites
- 1155US2013018058A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCAI SHAOPEI·Filed 2011·Application pending·0 cites
- 1254US2023234956A1Methods of making wee1 inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1353US2023212118A1Preparation of an selective estrogen receptor degraderRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1449US2011178097A1Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid saltsNOVARTIS AG·Filed 2006·Application pending·0 cites
- 1544US6632835B2Dibenzo[c]chromen-6-one derivatives as anti-cancer agentsNANODESIGN INC·Filed 2001·Granted Oct 14, 2003·9 cites·14 claims
- 1638US8222413B2Methods for synthesizing heterocyclic compoundsGALVIN GABRIEL·Filed 2006·Granted Jul 17, 2012·0 cites·23 claims
- 1732US2002147187A11,2-diphenyl-1-naphthyl ethene derivatives, analogs and use thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuguang Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →